Houston, TX, United States of America

Mithu Chanda

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mithu Chanda: Innovator in Dual Imaging and Radiochemotherapy

Introduction

Mithu Chanda is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of medical imaging and treatment through her innovative work. Her research focuses on developing compounds that enhance the effectiveness of dual imaging and radiotherapy.

Latest Patents

Mithu Chanda holds a patent for "Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications." This patent describes compositions and methods for dual imaging and for dual chemotherapy and radiotherapy. The invention involves compounds with the structure X—Y—X, where Y consists of two or more carbohydrate residues covalently attached to one another. The moieties X and X can be diagnostic or therapeutic agents attached to Y. The invention also includes methods for synthesizing these compounds and their applications in treating hyperproliferative diseases.

Career Highlights

Mithu Chanda is affiliated with the Massachusetts Institute of Technology, where she continues her research and development efforts. Her work has garnered attention for its potential to improve treatment outcomes in cancer therapy.

Collaborations

Mithu has collaborated with notable colleagues, including David J Yang and Dongfang Yu. Their combined expertise contributes to the advancement of innovative solutions in the medical field.

Conclusion

Mithu Chanda's contributions to dual imaging and radiochemotherapy exemplify the impact of innovative research in medicine. Her work not only enhances diagnostic capabilities but also paves the way for more effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…